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Doctor-patient relationship and quality of life in Irritable Bowel Syndrome: an 
exploratory study of the potential mediating role of illness perceptions and acceptance. 
 
Abstract 
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterised 
by unpredictable bowel symptoms. These can be difficult to manage, consequently impacting 
on sufferers’ quality of life (QoL). In addition, a strained doctor-patient relationship is 
independently reported in the qualitative literature. Given that the doctor is often the first 
port-of-call for sufferers, a difficult relationship may influence IBS sufferers’ subsequent 
management. Research suggests that illness perceptions are important in determining IBS 
outcomes in therapy; however, their association with doctor-patient relationship and QoL is 
yet to be investigated. This exploratory study aimed to investigate the association between 
doctor-patient relationship and QoL in IBS, as well as potential mediation of this relationship 
by illness perceptions. Online questionnaires measuring doctor-patient relationship, illness 
perceptions, acceptance and QoL, were completed by 167 participants (144 female, mean 
age=44.22 years, SD=15.91 years), who reported an IBS diagnosis from a doctor. 
Bootstrapped pathway analysis was used to model the relationship and mediation effects. 
There was a significant positive correlation between patient-doctor relationship and QoL, 
r=.258,n=167,p=.001. There was a significant indirect effect between doctor-patient 
relationship and QoL through illness coherence and acceptance (bootstrapped estimate=.058, 
95%CI Lower-Upper=.02,.095, p=.002). No other indirect effects were observed in 
combination with good fit indices for the other illness perceptions. Findings suggest a doctor-
patient relationship which fosters mutual understanding and helps patients make sense of 
symptoms, increases their ability to manage their IBS in a psychologically flexible manner, 
subsequently helping them maintain their QoL. 
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Introduction 
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder with 
prevalence rates in Europe and North America estimated around 10-15%, affecting twice as 
many women as men (Quigley et al., 2009). The disorder is characterised by symptoms such 
as constipation and/or diarrhoea, bloating and abdominal pain, seemingly without an 
underlying pathophysiological cause (Mayer, 2008). Individuals may experience highly 
variable and unpredictable episodes regarding symptoms, duration and potential triggers. This 
can make coping with IBS on a day-to-day basis difficult, resulting in IBS having a 
considerable negative effect on peoples’ lives (Dancey et al., 2009). Studies have shown that, 
although not a life-threatening illness, IBS sufferers report significantly impaired quality of 
life (QoL), not only in comparison to healthy controls (Amouretti et al., 2006), but also in 
comparison to other chronic disease sufferers, such as gastroesophageal reflux disease, 
asthma, migraines, diabetes and end-stage renal disease (Frank et al., 2002; Gralnek et al., 
2000). 
 Applied research has demonstrated the association of illness perceptions (patients’ 
illness beliefs) with IBS outcomes, highlighting their role as a mediator between Cognitive 
Behavioural Therapy (CBT) and subsequent improvements in symptom severity and social 
adjustment (Chilcot & Moss-Morris, 2013). Rutter & Rutter (2002) reported the association 
of low control, negative consequence and low coherence beliefs in predicting QoL, whilst 
demonstrating a possible mediation role of acceptance coping in this association. Similarly, 
de Gucht (2015) highlighted the role of illness perceptions, for example ‘consequences’ in 
mediating the relationship between severity and QoL. As such, it seems fostering positive 
illness perceptions is beneficial in IBS; however, the mechanistic pathways and best ways of 
achieving this have, as yet, not been ascertained.  
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Longitudinal research by Rutter & Rutter (2007) suggested that perceptions formed 
early in the illness trajectory may persist over time. Additionally, the Common Sense Model 
posits that individuals’ illness perception formation occurs as a function of background 
factors such as their experiences and relationships. They then dictate the action/coping 
response and the appraisal of this while individuals try to make sense of symptoms 
(Leventhal, Diefenbach & Leventhal, 1992). Given that the doctor is often the first port-of-
call for people with IBS, a difficult relationship may influence their illness beliefs, 
subsequent management and QoL. 
Negative experiences surrounding the doctor-patient relationship are frequently 
described in the literature. Variable and individual symptoms mean that diagnosis is often one 
of exclusion after diagnostic testing and varying treatment approaches are employed by 
primary care practitioners (Hungin et al., 2014), which may not address the patient’s exact 
combination of symptoms (Casiday et al., 2008; Lacy, Weiser & De Lee, 2009). Furthermore, 
patient and doctor may have different perceptions of the symptoms and severity of the IBS 
(Dalton et al. 2004). As a result, patients do not feel understood by the doctors who diagnose 
it and the adverse effect on their QoL is not acknowledged. Conversely, doctors struggle to 
provide successful treatment and adequate support because the exact aetiology of IBS is 
unidentified, leading to frustration for both parties in the patient-doctor dyad (Stenner, 
Dancey & Watts, 2000; Dhaliwal & Hunt, 2004; Di Palma & Herrera, 2012).  
 However, to our knowledge, these constructs have only been investigated 
independently. Considering the possible associations highlighted previously between doctor-
patient relationship, illness perceptions, acceptance (as a coping mechanism) and QoL, this 
exploratory mediation study aimed to investigate these relationships further. Pathways tested 
were determined by initial univariate analyses. However, specifically, we hypothesise that a 
better doctor-patient relationship will increase patients’ control and coherence beliefs, and 
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reduce their emotional distress beliefs, increasing their acceptance and resulting in improved 
QoL, as depicted in the model shown below (Figure 1).  
 
Insert Fig 1 here. 
 
 
Methods 
Design & Procedure 
This study employed an online survey tool to administer four self-report 
questionnaires. Participants were recruited via the website and monthly newsletter of an IBS 
patient support charity and an online patient forum. By following the web-link, interested 
respondents were directed to the information sheet and online survey. Respondents chose a 
unique and anonymous identifying code and gave their informed consent before proceeding 
through the demographics page and subsequent questionnaires by clicking ‘next’ to continue. 
Once ‘next’ had been clicked they were not able to return to that section, ensuring answers 
were not amended after further question topics had been seen. Finally, participants viewed a 
debrief page and were thanked for their time.  
The study received approval from the Institution’s Faculty of Health and Life 
Sciences Ethics Committee. 
 
Materials 
 Demographic questions, including age, gender, country of residence, duration and 
severity of symptoms (Likert scale from 1 (none) to 5 (very severe)), were embedded in the 
first page of the survey, followed by the questionnaires. 
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Doctor-patient relationship was measured using the ‘Patient-Doctor Relationship 
Questionnaire-9’ (PDRQ-9) (Van der Feltz-Cornelis et al., 2004). This nine item measure 
focuses on patient’s perspective of the relationship in primary care, with statements such as 
‘my PCP helps me’ rated on a Likert scale from 1 (not at all appropriate) to 5 (totally 
appropriate). Total scores range from 9-45; the higher the score, the more positively the 
relationship is perceived. In order to avoid confusion ‘PCP’ (primary-care practitioner) was 
substituted with ‘doctor’ and it was made clear this referred to the primary medical setting. 
The validity and reliability of this instrument has been demonstrated (Cronbach’s α= .94; Van 
der Feltz-Cornelis et al., 2004).  
Illness perceptions were assessed using the Illness Perception Questionnaire-Revised 
(IPQ-R) (Moss-Morris et al., 2002). For specificity, ‘your illness’ was replaced with ‘your 
IBS.’ Identity is assessed by participants choosing ‘Yes’ (=1) or ‘No’ (=0) in response to 
fourteen general and illness-related symptoms. The remaining 56 items are scored on a 5-
point scale; 1(strongly disagree) to 5(strongly agree). High summed scores for identity, 
timeline and consequences dimensions represent strong beliefs regarding the number of 
symptoms attributable to the disorder, adverse consequences and the chronic or cyclical 
nature of the disorder. High scores on the control and coherence dimensions indicate 
positively perceived controllability and good levels of understanding. Causal items are not 
summed but used for grouping/factor analysis. The validity and reliability of the IPQ-R have 
been ascertained in previous research; Cronbach’s α=.75 for identity and α≥.79 all other 
subscales (Moss-Morris et al., 2002). 
Acceptance was measured with the IBS-Acceptance & Action Questionnaire 
(IBSAAQ). The validity and reliability of this instrument has been demonstrated (Cronbach’s 
α>.80 for subscales and overall; Ferreira et al., 2013). A 7-point Likert scale ranging from 
0(never true) to 6(always true) is used to rate twenty items; a higher summed score indicates 
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a higher level of acceptance. A two-factor structure exists; ‘Activities Engagement’ 
corresponds to the pursuit of valued activities despite IBS and ‘IBS Willingness’ reflects 
willingness to be in contact with difficult psychological and physical IBS experiences.  
QoL was assessed using the IBS Quality of Life measure (IBS-QOL), an illness 
specific, validated, and reliable 34-item questionnaire (Cronbach’s α=.95) (Patrick et al., 
1998).  Items such as ‘I feel my life is less enjoyable because of my bowel problems’, are 
responded to on a 5-point scale from 1(not at all) to 5(extremely), which is then reversed. 
Once summed, the total score is transformed to a 0-100 scale for ease of interpretation. The 
higher the score, the better the patient’s QoL.  
 
Data Analysis 
Statistical analysis was performed using the statistical packages SPSS and MPlus. 
Missing data was handled by case-wise mean substitution, e.g. where missing data was 
present, an individual’s average score from the corresponding subscale was imputed. This 
occurred in accordance with questionnaire instructions. 
The bootstrapping technique was used to test direct and indirect effects between the 
constructs (two-tailed significance). Maximum likelihood estimation was used, and all 
models controlled for IBS severity and age. Five hundred bootstrap samples were generated 
for a 95% confidence interval effect. This procedure consists of non-parametric resampling 
with replacement, which is done many times and from which a new sampling distribution can 
be created, allowing the significance of the model pathway to be tested (Shrout & Bolger, 
2002).  
Model fit was evaluated using the following indices (cut-off values for good fit are 
indicated in the brackets, e.g. a CFI value of .95 or more indicates good fit): Chi-Squared 
(p≥.05), Comparative Fit Index (CFI; ≥.95) and Root mean square error of approximation 
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(RMSEA; ≤.05) and Tucker–Lewis Index (TLI; ≥.95). These are commonly used criteria 
advocated in the literature for evaluating model fit (Hooper, Coughlan & Mullen, 2008). All 
models were adjusted for age and illness severity. 
 
Results 
Participants 
In total 284 responses were logged. Forty-one of these were removed due to 
duplication or no responses (i.e. participants registering their consent, but not proceeding to 
answer any further questions). Nine participants were excluded because they had not received 
an IBS diagnosis from their doctor. Due to healthcare differences in non-UK countries, we 
excluded participants from any other country. The final sample consisted of 167 participants 
(144 female), see table 1 for sample characteristics.  
 
Insert Table 1 here. 
 
 There was no significant difference between females and males on the outcome 
variable QoL, or any of the illness perception variables. This was with the exception of 
personal control, where females (mean=20.47, s.d.=5.08) scored higher than males 
(mean=18.09, s.d.=4.71), F(1,165) = 4.461, p<.05. However, this difference was not 
significant at the adjusted α-level (p<.0056). 
In terms of IBS subtype, 64 participants reported having IBS-D (diarrhoea), 25 
reported IBS-C (constipation), 73 reported IBS-A (alternating/mixed) and 5 did not know/did 
not respond. There was no significant association of subtype with any illness perception 
variables or QoL (all p>.10). 
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Correlation analyses 
Initially, two-tailed correlations were calculated to assess the associations between all 
constructs. The correlations between each of the variables and, i) the predictor variable 
(doctor-patient relationship) and ii) the outcome variable (QoL) of interest, are shown in 
Table 2. 
 Of the illness perceptions, illness coherence and emotional representations in 
particular were significantly correlated with doctor-patient relationship. Regarding QoL, 
consequences and emotional representations were highly correlated, along with the control 
perceptions, illness coherence and also Acceptance.  
  
Insert Table 2 here. 
 
Accordingly, we conducted individual mediation analyses to investigate the direct and 
indirect effects of the pathway from doctor-patient relationship to QoL, via the variables 
which were shown to be significantly correlated with QoL: illness perceptions (consequences, 
personal control, treatment control, illness coherence, emotional representation) and 
Acceptance. 
Correlation analyses were also used to check the associations between age, duration 
and severity, with the illness perception variables and QoL outcome. Age was not associated 
with any of these variables, except illness coherence, r(165) = -.175, p<.05. Duration was not 
associated with any of these variables, except personal control r(158) = -.209, p<.01 and 
treatment control r(158) = -.168, p<.05,. Severity correlated significantly with identity r(162) 
= .249, p<.01, timeline (chronic) r(162)=.286, p<.001, consequences r(162) =.519, p<.001, 
treatment control r(162) = -.216, p<.01, emotional representations r(162) = .337, p<.001, and 
QoL r(162) = -.392, p<.001.  
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Mediation analyses 
Doctor-patient relationship did not have a direct effect on QoL in any of the specified 
models, highlighting the importance mediating factors in determining effect on QoL. 
Mediating (i.e. indirect) effects are considered significant when the upper and lower bounds 
of the confidence interval do not contain the value zero and p ≤.05. Fit indices and indirect 
effects are shown in table 3 (all values given are standardised). 
 
Insert Table 3 here. 
 
Discussion 
This exploratory study aimed to investigate the association between doctor-patient 
relationship and QoL in IBS, by testing mediating influences of illness perceptions and 
acceptance. Specifically, illness perceptions shown to be highly correlated with the QoL 
outcome, which were therefore included in the path analyses, were: consequences, personal 
control, treatment control, illness coherence and emotional representations.  
Of these, illness coherence was the only perception that contributed to a model of 
good fit as well as demonstrating a significant mediating effect when combined with 
acceptance (see table 3), in line with our hypothesis. The association is summarised in the 
following model (Figure 2). 
 
Insert Fig 2 here. 
 
Given that the correlation between doctor-patient relationship and illness coherence 
was the strongest of all the variables, this finding is perhaps unsurprising. However, previous 
research suggested that the ‘consequences’ and ‘cure/control’ dimensions could also play an 
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important role (Rutter & Rutter, 2002). One difference must be highlighted; the current 
research utilised the IPQ-R whereas Rutter and Rutter (2002) used the Illness Perception 
Questionnaire (IPQ). The IPQ has since been amended to improve its measurement properties 
and include other important perception components, one of these being illness coherence. It 
could be argued that the use of the less comprehensive measure previously meant that illness 
coherence was not measured and so its predictive involvement could not have been reported. 
Indeed, this deduction is supported by research which demonstrated that ‘comprehensibility’ 
(understanding of the condition), along with consequences, was significantly associated with 
QoL impact (Ferreira et al., 2010).  
Additionally, although no previous research has empirically linked doctor-patient 
relationship and illness perceptions in IBS, findings from doctor-patient relationship studies 
tend to centre around factors such as concordant (or discordant) views, shared knowledge and 
mutual understanding (Casiday et al., 2008; Dalton et al., 2004; Di Palma & Herrera, 2012; 
Bijkerk et al., 2003). Additionally, a disappointing experience of healthcare in the early 
stages together with a lack of a coherent illness narrative is common in many other 
“medically unexplained” conditions, whereby coherent ‘symptom stories’ are thought to help 
patients manage their condition better as the understanding or ‘sense-making’ can be seen as 
a transaction between the individual, healthcare professionals and a coherent illness narrative, 
which acts upon well-being (Kirmayer et al., 2004; Burton et al., 2015). Thus, it seems illness 
coherence may be the illness perception of particular importance when doctor-patient 
relationship is introduced into the equation. 
The cross-sectional design employed here means that the directional causality remains 
speculative. However, the strong rationale which informed model specification suggests that 
using path analyses to confirm a directional relationship is not inappropriate (Pearl, 2012). 
Nonetheless, illness perceptions are activated on symptom presentation, and subsequently 
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dictate individuals’ health behaviour: one such example being advice seeking (Diefenbach & 
Leventhal, 1996). Therefore, it may be more appropriate to view the doctor-patient 
relationship as an important influencing factor across the illness coherence trajectory, rather 
than a solely a preceding factor.  
As Dhaliwal and Hunt (2004) point out, the local doctor is often a patient’s first port-
of-call. Additionally, as Rutter and Rutter (2007) found, illness perceptions for chronic 
conditions such as IBS will probably remain stable over time, unless challenged directly. 
Therefore, experiences are likely to be evaluated in light of beliefs formed, reinforced or 
modified in the early stages, placing substantial value on patients’ positive early interactions 
with their GP. This means the early appointments are undoubtedly a valuable opportunity to 
influence IBS trajectory. As the present study shows, maximising illness coherence 
(essentially helping patients make sense of symptoms, treatment and management options) 
could result in improved QoL. Importantly, however, this must be done in such a way which 
minimises conflict and disparity in beliefs, to avoid the very issues that so many previous 
studies raise, such as discordance and patients feeling misunderstood. As Drossman (2013) 
describes when discussing the importance of good communication in healthcare, mutual 
understanding could, for example, be achieved by the doctor eliciting patients’ beliefs and 
current understanding at the beginning of the consultation and then being mindful of these 
throughout. This sentiment is echoed in a recently published patient’s perspective, whereby 
increasing understanding and providing clear explanations with patient relevance were 
important factors in successful self-management (Errico, 2017). Indeed, ‘care in medically 
unexplained symptoms’ leaflets advocate very similar strategies; for example, avoid 
mismatches in beliefs by explaining rather than just normalising symptoms (Chitnis et al., 
2011). To further clarify the role of the doctor-patient relationship within this illness 
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coherence continuum and identify specific mechanisms underlying the association, a 
longitudinal or interventional approach in future research would be of great value.  
A further valuable avenue for future research would be to investigate the role of 
acceptance in IBS, relative to both doctor-patient relationship and QoL. The correlations with 
both the primary predictor and outcome variables in the present study, along with its role as a 
necessary mediator in all models, suggest this could also be an important factor in 
determining IBS patient outcomes. Little research has investigated the role of acceptance in 
IBS, although it has been suggested as a therapeutic approach worth pursuing (Naliboff, 
Frese & Rapgay, 2008). One could hypothesise improving a patient’s psychological 
flexibility and their ability to pursue valued action, enables them to uphold their QoL (see 
Naliboff et al., 2008; Ferreira et al., 2013; Hayes et al., 2006, for more detailed discussion of 
Acceptance and Commitment Therapy). However, further research is needed to explore the 
underlying mechanisms behind such tentative links. 
It is imperative to stress that these conclusions are not aiming to blame doctors for the 
problematic outcomes IBS patients may experience. The variable and functional nature of the 
disorder makes successful care very difficult, especially in the pressured timeframe of 
medical appointments (Tsiga et al., 2013). Bearing this (and the advantages of a therapeutic, 
longer term care pathway for IBS) in mind, a solution could be to develop a care pathway 
focussing on factors such as illness coherence, mutual understanding and patient-led 
management, which could be delivered by other health professionals such as health 
psychologists. Gormley (2014) also considers this in his proposal for an integrated and 
inclusive healthcare framework for MUS patients when he highlights the need for ‘a sensitive 
and valued service for this substantial client group’ (pp. 89).  
The present study has several strengths, including its theoretical and evidence based 
rationale and use of validated disease-specific measures (Ferreira et al., 2013; Patrick et al., 
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1998). Additionally, to our knowledge it is a novel study and is the first to explore the 
association between doctor-patient relationship and QoL in IBS, using mediation analyses. 
While the data reported here are cross-sectional, they do shed an interesting new light on the 
interplay between the doctor-patient relationship, illness perceptions and QoL in IBS, which 
warrants further consideration to confirm the causal pathways. However, some limitations 
must also be considered. The female-to-male ratio of this sample (85% female) does not 
mirror epidemiological prevalence rates of IBS. Nevertheless, it is similar to ratios reported 
by similar previous research also using an IBS network to access participants (Rutter & 
Rutter, 2002; de Gucht, 2015). Additionally, it may be that individuals who experience 
negative QoL outcomes or are not satisfied with the support they receive, are more likely to 
visit IBS support websites, potentially biasing findings towards the adversely affected 
subsection of the IBS population. Future research should consider a large scale, community 
study to encompass a wide range of doctor-patient and QoL experiences, aiding model 
identification. 
In summary, this novel, exploratory study aimed to investigate whether an association 
between doctor-patient relationship and QoL in IBS exists, and to model this association via 
possible mediators; illness perceptions and acceptance. Illness coherence was most strongly 
correlated with doctor-patient relationship and the only illness perception to yield a model of 
good fit, directly preceding acceptance and, indirectly, QoL. This illustrates, and explains, the 
importance of a relationship which fosters mutual understanding and reduces belief disparity; 
in turn influencing the patient’s ability to make sense of their IBS which then, according to 
the model, positively influences their acceptance of the condition and subsequent QoL. 
Although further research is required to explore the mechanisms of this pathway fully, this 
preliminary research raises some early implications for the IBS care pathway. Medical 
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appointments could be seen as an ideal target point for IBS intervention strategies aimed at 
maximising patients’ illness coherence and proximally influencing patients’ QoL.  
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Table 1 Participant sample characteristics 
 Mean (SD, range) 
Age (years) 44.22 (15.91, 18-75) 
Duration (years) 11.99 (10.82, 0.25-41) 
Severity (scale: 0-5) 3.62 (.82, 2-5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
*p<.05, **p<.005, ***p≤ .001 
 
Table 2 Correlations of the primary independent and dependent variables, with the other variables 
 Doctor-patient relationship 
r 
Quality of Life 
r 
Doctor-patient relationship - .258*** 
Identity -.222** -.239** 
Timeline (chronic) .014 -.262*** 
Timeline (cyclical) -.022 -.038 
Consequences -.160* -.650*** 
Personal control .230** .303*** 
Treatment control .197* .369*** 
Illness coherence .312*** .352*** 
Emotional representations -.306** -.696*** 
Acceptance .228** .712*** 
Quality of Life .258*** - 
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Table 3 Summary of fit and indirect pathway significance for each of the illness perception models  
Mediating illness 
perceptions 
Model fit Significant indirect pathways (bootstrapped point estimate, 95% CI) 
Illness perceptions  
alone 
      Illness perceptions 
         + Acceptance 
Acceptance 
alone 
Consequences Not good fit  
X2(5, N=167) = 60.220, p<.001, 
RMSEA=.257, CFI=.816, 
TLI=.557. 
No  
(.040, 95%CI = -.009, 
.089; p=.106) 
Yes 
(.050, 95% CI = .001, 
.099; p=.047) 
Yes 
(.061, 95% CI = .001,  
.121; p=.045) 
Personal control Good fit 
X2(5, N=167) = 6.894, p=.2286, 
RMSEA=.048, CFI=.990,  
TLI=.975. 
No 
(.015, 95% CI = -.009, 
.04; p=.224) 
No 
(.025, 95%CI = -.001, 
.051; p=.063) 
Yes 
(.107, 95% CI = .017, 
.198; p=.02) 
Treatment control Good fit    
X2(5, N=167) = 10.461, p=.0632, 
RMSEA=.081, CFI=.971, 
TLI=.930. 
No 
(.028, 95% CI = -.003, 
.058; p=.076) 
No 
(.023, 95% CI = -.003, 
.049; p=.089) 
Yes 
(.107, 95% CI = .018, 
.196; p=.018) 
Illness coherence Good fit 
X2(5, N=167) = 9.371, p=.0952, 
RMSEA=.072, CFI=.979, TLI=.949. 
No  
(.025, 95% CI = -.012, 
.062; p=.185) 
Yes 
(.058, 95% CI = .02, .095; 
p=.002) 
No 
(0.072, 95% CI = -.016, 
.159; p=.108) 
Emotional 
representations 
Not good fit  
X2(5, N=167) = 28.195, p<.001, 
RMSEA=.167, CFI=.925, 
TLI=.820 
Yes 
(.130, 95% CI = .051, 
.208; p=.001 ) 
Yes 
(.130, 95% CI = .024, 
.108; p=.002) 
No 
(.016, 95% CI = -.029, 
061, p=.481) 
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